← All companies
RLAY annual net income
Relay Therapeutics, Inc.
RLAY - CIK 0001812364
Market cap$2.58 B
Rank#1918
SEC filings506
Relay Therapeutics, Inc. net income by year
Relay Therapeutics, Inc. (RLAY) reported net income of -$276.48M for fiscal year 2025, as filed in its audited annual report with the SEC.
RLAY net income 2019-2025
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | -$276.48M | +18.1% |
| FY 2024 | -$337.71M | +1.2% |
| FY 2023 | -$341.97M | -17.7% |
| FY 2022 | -$290.51M | +20.2% |
| FY 2021 | -$363.87M | -594.3% |
| FY 2020 | -$52.41M | +30.4% |
| FY 2019 | -$75.31M | - |
Net Income of similar companies
Frequently asked questions
How much profit does Relay Therapeutics, Inc. make?
Relay Therapeutics, Inc. (RLAY) reported net income of -$276.48M for fiscal year 2025, as filed in its audited annual report with the SEC.
How has Relay Therapeutics, Inc.'s net income changed over time?
Between fiscal 2019 and fiscal 2025, Relay Therapeutics, Inc.'s net income declined from -$75.31M to -$276.48M.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.